Diamyd Majority owners exercise 10,000 warrants each

Diamyd Medical is announcing today that the company’s two principal owners, Bertil Lindquist and Anders Essen-Möller, is each converting 10,000 Diamyd TO 2B warrants into shares in Diamyd Medical AB. The exercise price is SEK 100 per share.

The transaction is being carried out by exercise of the warrants that both principal owners previously acquired from Diamyd Medical’s President and CEO, Elisabeth Lindner. The warrants Diamyd TO 2B are traded until April 8 on First North Stock Exchange, and can be converted into series B shares in Diamyd Medical AB from March 16 until April 17, 2009. The exercise price is SEK 100.

Tags: